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Abstract
Objectives—This article is a systematic review of the effectiveness of three practices for 
reducing blood culture contamination rates: venipuncture, phlebotomy teams, and prepackaged 
preparation/collection (prep) kits.
Design and methods—The CDC-funded Laboratory Medicine Best Practices Initiative 
systematic review methods for quality improvement practices were used.
Results—Studies included as evidence were: 9 venipuncture (vs. versus intravenous catheter), 5 
phlebotomy team; and 7 prep kit. All studies for venipuncture and phlebotomy teams favored 
these practices, with meta-analysis mean odds ratios for venipuncture of 2.69 and phlebotomy 
teams of 2.58. For prep kits 6 studies’ effect sizes were not statistically significantly different from 
no effect (meta-analysis mean odds ratio 1.12).
Conclusions—Venipuncture and the use of phlebotomy teams are effective practices for 
reducing blood culture contamination rates in diverse hospital settings and are recommended as 
evidence-based “best practices” with high overall strength of evidence and substantial effect size 
ratings. No recommendation is made for or against prep kits based on uncertain improvement.
☆Funding source: CDC funding for the Laboratory Medicine Best Practices Initiative to Battelle Centers for Public Health Research 
and Evaluation under contract W911NF-07-D-0001/DO 0191/TCN 07235.
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Introduction
A blood culture is the primary laboratory test for diagnosing serious blood stream infections, 
including septicemia or sepsis, and in directing appropriate antibiotic therapy [1–3]. 
Septicemia among hospitalized patients is widely prevalent and was the single most 
expensive condition treated in U.S. hospitals affecting nearly one of every 23 patients 
(4.2%) at an aggregate cost of nearly $15.4 billion (4.3% of all hospital costs) in 2009 [4]. 
The number of hospital stays for septicemia more than doubled between 2000 and 2009 [5], 
and it had an in-hospital mortality rate of about 16% in 2009, more than 8 times higher than 
other stays [4]. Accurate blood culture results are essential for providing safe, timely, 
effective and efficient care for patients with serious infections. These procedures also affect 
healthcare expenses as well as public health tracking and reporting of healthcare acquired 
infections and bloodstream infection rates for infection control activities [3].
Quality gap: blood culture contaminationa
False positive blood culture test results are common and are caused by contamination that 
occurs from the introduction of organisms outside the bloodstream (e.g., skin or 
environmental contaminants) into the sample of blood obtained for culture [6] that cannot be 
completely eliminated [7–9]. While a relatively small percentage of all blood cultures are 
contaminated, it represents a large proportion of all positive results and therefore has been 
recognized as an important quality problem for decades [3]. Although no definitive estimate 
is available, of all positive cultures, 20% to 50% are likely false positives [10–12]. 
According to the American Society for Microbiology (ASM) and the Clinical Laboratory 
Standards Institute (CLSI) overall blood culture contamination rates should not exceed 3% 
[1,2], however reported contamination rates in hospitals vary widely ranging from 0.6% to 
12.5%, with the highest rates associated with emergency department settings [3,6–9,11,13–
20]. One study reported a 26% contamination rate in pediatric outpatients [21]. False 
positive results can lead to inappropriate patient diagnosis, follow-up, and unnecessary 
treatment [3,9,11], creating substantial adverse consequences for patients and cost burdens 
for the healthcare system. This includes re-collection of blood cultures, other laboratory tests 
for reevaluation, incorrect or delayed diagnosis due to errors in clinical interpretation, 
inappropriate antibiotic treatment as well as unnecessary and longer hospital stays and costs 
associated with these outcomes [3,12,14,22,23].
To reduce this important quality gap and its consequences, it is essential to identify effective 
practices for reducing blood culture contamination rates. Other than the use of skin 
antiseptics [24] and changing needles prior to inoculation of blood culture bottles [25], no 
aSee Glossary for more information on the definition of blood culture contamination and other terms.
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systematic reviews of quality improvement practice evidence of effectiveness have been 
conducted. The use of strict aseptic techniques by healthcare workers when obtaining blood 
culture specimens is an important factor in reducing contamination [9], and there is 
sufficient evidence to evaluate the effectiveness of three practices used to obtain blood 
culture specimens: venipuncture, phlebotomy teams and prepackaged prep kits. The purpose 
of this article is to evaluate evidence of these practices’ effectiveness at reducing blood 
culture contamination (false positive) rates by applying the CDC Laboratory Medicine Best 
Practices Initiative’s (LMBP) systematic review methods for quality improvement practices 
and translating the results into evidence-based guidance [26].
Methods
This evidence review followed the CDC’s Laboratory Medicine Best Practices Initiative’s 
(LMBP) “A-6 Cycle” systematic review methods for evaluating quality improvement 
practices and reported in detail elsewhere [26]. This approach is derived from previously 
validated methods, and is designed to transparently evaluate the results of studies of practice 
effectiveness to support evidence-based best practice recommendations. A review team 
conducts the systematic review including a review coordinator and staff specifically trained 
to apply the LMBP methods. Guidance on the conduct of the systematic review and draft 
recommendations is provided by an expert panel including individuals selected for their 
diverse perspectives and expertise in the review topic, laboratory management and evidence 
review methods.b The results of the evidence review are translated into an evidence-based 
best practice recommendation by the expert panel for approval by the LMBP Work-group, 
an independent, multi-disciplinary group composed of 15 members with expertise in 
laboratory medicine, clinical practice, health services research and health policy.
The question answered by this evidence review is: What practices are effective for reducing 
blood culture contamination? This review question is addressed in the context of an analytic 
framework for the quality issue of blood culture contamination depicted in Fig. 1. The 
relevant PICO elements are:
• Population: all patients in healthcare settings who have a blood culture specimens 
collected
• Intervention (practice) versus Comparison:
– venipuncture versus intravenous catheter collection
– phlebotomy team versus non-phlebotomist staff collection
– prepackaged prep kit versus no prep kit for venipuncture collection
• Outcome: blood culture contamination rate is the direct outcome of interest
The three practices being evaluated in this review are venipuncture, puncture of a vein 
through the skin to withdraw blood as opposed to an indwelling catheter in the vein to 
withdraw blood (or other purposes such as delivery of antibiotics, pain medication, and 
bSee Appendix A for the LMBP Blood Culture Contamination Expert Panel Members and LMBP Workgroup members. See 
Appendix Edits/Notes.
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saline solution); use of a phlebotomy team of certified or trained phlebotomists for specimen 
collection using venipuncture instead of other healthcare personnel (e.g., physicians, interns, 
nurses); and prepackaged prep kits of aseptic supplies for collection of blood specimens by 
venipuncture that are commercially purchased versus using usual disinfectant supplies that 
are not prepackaged.
The search for studies of practice effectiveness included a systematic search of multiple 
electronic databases, hand searching of bibliographies from relevant information sources, 
consultation with and references from experts in the field including members of the expert 
panel (Appendix A), and by solicitation of unpublished quality improvement studies 
resulting in direct submissions to the Laboratory Medicine Best Practices Initiative.c The 
literature search strategy and terms were developed with the assistance of a research 
librarian and included a systematic search in September 2011 of three electronic databases 
(PubMed, Embase and CINAHL) for English language articles from 1995 to 2012 about 
human subjects. The search contained the following Medical Subject Headings: allied health 
personnel, blood, blood specimen collection, catheterization, disinfectants, health personnel, 
laboratory personnel, phlebotomy as well as these keywords: anti-infective agent, local; 
antisepsis; blood sampling; blood culture; catheter; contaminants; contamination; costs; 
disinfection; health care cost(s); healthcare personnel; intravenous catheter; microbiology; 
paramedical personnel; phlebotomists; phlebotomy team; skin; skin decontamination; 
quality; and venipuncture.
Included studies were considered to provide valid and useful information addressing the 
review question, with findings for at least one blood culture contamination rate outcome 
measure. To reduce subjectivity and the potential for bias, all screening, abstraction and 
evaluation was conducted by at least two independent reviewers, and all differences were 
resolved through consensus. The effect size for each study was standardized using its 
reported data and results to calculate an odds ratio (OR)d since the outcome of interest is 
dichotomous (i.e., blood culture is contaminated or is not contaminated) and the findings for 
these practices are typically expressed in terms of rates or percentages. The OR compares 
the intervention practice to the comparison practice, or comparator, in terms of the relative 
odds of a successful outcome (i.e., no contamination versus contamination). Each study is 
assigned one of three quality ratings (Good, Fair, Poor) and one of three effect size ratings 
(Substantial, Moderate or Minimal/None).e
The results from the individual effectiveness studies are aggregated into a practice body of 
evidence that is analyzed to produce the systematic review results for translation into an 
evidence-based recommendation (Recommend, No recommendation for or against, 
Recommend against). Both qualitative and quantitative analyses are used to assess the effect 
size consistency and patterns of results across studies [27], and to rate the overall strength of 
the body of evidence for practice effectiveness (High, Moderate, Suggestive, Insufficient). 
cMore information on submission of unpublished studies to the Laboratory Medicine Best Practices Initiative is available at 
www.futurelabmedicine.org.
dSee Glossary for more information on odds ratios.
eThe criteria for a substantial effect size rating: OR>2.0 and significantly different from OR=1.0 at p=0.05 (i.e., the lower limit of the 
95% confidence interval is>1.0).
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Criteria for these ratings are described in greater detail elsewhere [26,28]. The qualitative 
analysis synthesizes the individual studies to convey key study characteristics, results and 
evaluation findings summarized in a body of evidence table. The quantitative analysis is 
provided using meta-analysis of results from similar individual studies to provide a weighted 
average effect size and 95% confidence interval (CI) estimated using a random-effects 
modelf and presented in a forest plot [29,30] with the individual studies’ and overall mean 
odds ratios along with their respective 95% confidence interval upper and lower limits. The 
I2 statistic is used to estimate the percent of variability associated with between-study 
differences [31,32].
Evidence review synthesis and results
The search identified 456 separate bibliographic records that were screened for eligibility to 
contribute evidence of effectiveness for the three practices (venipuncture, phlebotomy 
teams, and prepackaged prep kits) with respect to blood culture contamination rate 
outcomes. After initial screening, 348 of these records were excluded as off-topic, and 87 
were excluded for not meeting effectiveness study inclusion criteria (i.e., a study using data 
evaluating a practice of interest with at least one finding for a relevant blood culture 
contamination rate outcome measure). A total of 21 full-text studies met the review 
inclusion criteria. A systematic review flow diagram in Fig. 2 provides a breakdown of the 
search results. The full-text review and evaluation of the 21 eligible studies (10 
venipuncture; 6 phlebotomy team; 6 prep kits), with one evaluating two practices, resulted in 
excluding 4 studies (1 venipuncture; 1 phlebotomy team; 2 prep kit) for not meeting the 
minimum required LMBP study quality inclusion criteria. Appendix C provides a Body of 
Evidence table for each practice, as well as abstracted and standardized information and 
study quality ratings in evidence summary tables for each of the 21 eligible studies. 
Appendix B provides bibliographic reference information for these studies. A total of 17 
studies are included in this review as evidence of practice effectiveness (9 venipuncture; 5 
phlebotomy team; 4 prep kits). One published study contained data evaluating 2 practices 
(Weinbaum [19]) and another published study (Wilson et al., 2000, Appendix B) contains 4 
studies at separate sites resulting in a total of 7 prep kit studies.
Venipuncture practice effectiveness evidence
Information on the nine published studies that comprise the practice effectiveness body of 
evidence comparing venipuncture to catheter blood sample collection with respect to blood 
culture contamination rates is summarized in Table 1. The publication dates for these studies 
range from 1999 (DesJardin [34]) to 2011 (Weddle [18]), with the earliest study time 
periods beginning in 1994 (DesJardin [34]; Martinez [39]). Of the nine studies, seven were 
rated “Good” study quality and two were rated “Fair.” Paired blood cultures from the same 
patient (one collected by venipuncture and one by catheter) were used as the study samples 
in five studies (Beutz [35], DesJardin [34], Everts [40], Martinez [39], Mcbryde et al., 2005, 
Appendix B), ranging from 300 (Beutz [35]) to 1408 pairs (Everts [40]). The four non-
fRandom-effects model assumes there is no common population effect size for the included studies and the studies’ effect size 
variation follows a distribution with the studies representing a random sample. This is in contrast to the fixed-effects model which 
assumes a single population effect size for all studies and that observed differences reflect random variation.
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paired study samples (Norberg [38], Qamruddin et al., 2007, Appendix B, Ramsook et al., 
2000, Appendix B, Weddle [18]) ranged in size from 1138 (Qamruddin et al., 2007, 
Appendix B) to 4108 total blood cultures (Norberg [38]). These studies all involve hospital 
patients and include a range of settings as follows: all patients (adult and pediatric), (Everts 
[40]), all adult patients, (Qamruddin et al., 2007, Appendix B) intensive care units (Beutz 
[35], Martinez [39]), an oncology ward (DesJardin [34]), and pediatric emergency 
departments (Norberg [38], Ramsook et al., 2000, Appendix B, Weddle [18]). Seven studies 
were conducted in U.S. hospitals, two in the same hospital (DesJardin [34] and Martinez 
[39]), one in the UK (Qamruddin et al., 2007, Appendix B), and one in Australia (Mcbryde 
et al., 2005, Appendix B).
Body of evidence qualitative analysis
Evidence of practice effectiveness for reducing blood culture contamination rates by using 
venipuncture indicates consistent and substantially lower rates compared to catheter 
collection with a high strength of evidence in hospital settings (Table 1). The venipuncture 
odds ratios for all nine studies included in the body of evidence (with >1.0 favoring 
venipuncture over catheter blood draws) ranged from 1.53 (95% CI: 0.88–2.68) to 5.60 
(95% CI: 3.61–8.69). The odds ratio for six of the nine studies exceeded 2.0 for a 
“Substantial” effect size rating. For the remaining three studies, the lower limit of their odds 
ratios’ 95% confidence interval is less than 1.0, with the lowest at 0.88. The odds ratio 
results of the five studies using paired blood cultures provide more reliable evidence and 
ranged from 1.88 (95% CI: 0.88–3.99) to 5.60 (95% CI: 3.61–8.69), offering greater support 
overall for the effectiveness of venipuncture compared to those of the four less suitable 
study designs ranging from 1.53 (95% CI: 0.88–2.68) to 3.46 (95% CI: 2.55–4.69). All three 
studies in the pediatric emergency department setting have similar high odds ratios ranging 
from 2.96 (95% CI: 1.96–4.47) to 3.46 (95% CI: 2.55–4.69).
Meta-analysis
The forest plot in Fig. 3 presents the meta-analysis effect size results for venipuncture 
compared to catheter blood culture contamination rates for the body of evidence estimated 
using a random effects model. The odds ratios for all nine studies included in the body of 
evidence favor venipuncture over catheter blood draws with a mean odds ratio of 2.69 (95% 
CI: 2.03–3.57), strongly favoring venipuncture over catheter blood collection for reducing 
blood culture contamination rates. The meta-analysis results show moderate statistical 
heterogeneity (Q=19.5, p=0.012), with approximately 60% of the variability in results 
attributable to between-study differences. (I2=59.0) [33].
Phlebotomy team practice effectiveness evidence
Of the five studies included in the body of evidence for phlebotomy team practice 
effectiveness (Table 2), all were conducted in large U.S. hospitals, two in emergency 
departments only (Gander [41], Sheppard [13]). One of the studies is unpublished (Geisinger 
Wyoming Valley, 2009, Appendix B) and four are rated “Good” study quality and one is 
rated “Fair.” Of the included studies, three had phlebotomy team comparison groups using 
only venipuncture for blood draws (Gander [41], Surdulescu [16], Weinbaum [19]) which 
provide more reliable evidence for estimating phlebotomy team practice effectiveness than 
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the two studies which include both venipuncture and catheter draws in their comparison 
groups. The earliest reported study time period began in 1993 (Surdulescu [16]) and the 
most recent began in 2009 (Geisinger Wyoming Valley, 2009, Appendix B). All of the 
studies had large sample sizes exceeding 1000 blood cultures, and overall appear to 
represent a broad and diverse hospital patient population.
Body of evidence qualitative analysis
The evidence of practice effectiveness for phlebotomy teams at reducing blood culture 
contamination rates indicates consistent and substantial improvement compared to 
collections by non-phlebotomist staff with a high strength of evidence in hospital settings 
(Table 2). For all five studies in the practice body of evidence, the phlebotomy team odds 
ratio exceeded 2.0 (favoring phlebotomy teams over non-phlebotomist staff), ranging from 
2.09 (95% CI: 1.68–2.61) to 4.83 (95% CI: 1.53–15.28), and were all statistically 
significantly different from 1.0, exceeding the threshold criteria for a “Substantial” effect 
size rating. The phlebotomy practice odds ratio effective size for the three studies with a 
venipuncture only comparison group ranged from 2.09 (95% CI: 1.68–2.61) to 4.34 (95% 
CI: 1.82–10.36), which is slightly lower and potentially more representative of the true 
effect than the range for the two other studies that included catheter draws with odds ratios 
of 2.93 (95% CI: 2.13–4.02) and 4.83 (95% CI: 1.53–15.28). There is not a notable 
difference in the effect sizes of the two studies conducted in emergency departments with 
odds ratios 2.51 (95% CI: 1.84–3.43) and 4.83 (95% CI: 1.53–15.28) compared to the three 
studies conducted hospital-wide.
Meta-analysis
The forest plot in Fig. 4 presents the meta-analysis effect size results for the phlebotomy 
team compared to non-phlebotomist collection blood culture contamination rates for the 
body of evidence estimated using a random effects model. The odds ratios for all five 
included studies favor phlebotomy teams over non-phlebotomists, with a mean odds ratio of 
2.58 (95% CI: 2.07–3.20) strongly favoring phlebotomy teams for reducing blood culture 
contamination rates. The meta-analysis results are homogeneous (Q=6.2, p=0.182) with 
moderate variability attributed to between study differences (I2=35.8%) [33].
Prepackaged prep kit practice effectiveness evidence
Of the four published studies included in the prepackaged prep kit practice effectiveness 
body of evidence (Table 3), one (Wilson et al., 2000, Appendix B) contains four separate 
trials, each at a different hospital, yielding a total of seven studies. All seven studies were 
conducted in hospitals, six in the U.S. and one in the UK (McLellan [6]), and involved 
venipuncture blood collections in a broad range of hospital settings by multiple types of staff 
(i.e., phlebotomists, healthcare technicians, staff physicians and interns). One of the studies 
was rated “Good” study quality and six were rated “Fair.” The study time periods for five of 
the seven studies began prior to 2000 (Wilson et al., 2000, Appendix B, Weinbaum [19]), 
with only one study period occurring in the last five years (McLellan [6]). The study sample 
sizes ranged from 495 (Weinbaum [19]) to 6,460 total blood cultures (Wilson et al., 2000, 
Appendix B).
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Body of evidence qualitative analysis
The evidence of practice effectiveness for prepackaged prep kits at reducing blood culture 
contamination rates often indicated either minimal or no improvement compared to 
venipuncture collections without prep kits in hospital settings (Table 3). For six of the seven 
studies in the practice body of evidence, the prep kit odds ratio was not statistically 
significantly different from 1.0. (i.e., no difference between blood culture contamination 
rates for prep kits versus no prep kits) with one study showing substantial improvement. The 
odds ratios for the seven individual studies ranged from 0.91 (95% CI: 0.62–1.34) to 3.68 
(95% CI: 1.27–10.73). Five of the studies received a “Minimal/None” effect size rating with 
odds ratios ranging from 0.91 (95% CI: 0.62–1.34) to 1.22 (95% CI: 0.79–1.87), one was 
rated “Moderate,” and only one study exceeded the threshold criteria for a “Substantial” 
effect size rating.
Meta-analysis
The forest plot in Fig. 5 presents the meta-analysis blood culture contamination rate effect 
size results for venipuncture collections with prepackaged prep kits compared to without 
prep kits for the practice body of evidence estimated using a random effects model. The 
mean odds ratio of 1.12 (95% CI: 0.94–1.35) is homogeneous (Q=7.9, p=0.242) and does 
not favor prepackaged prep kits for reducing blood culture contamination rates. The meta-
analysis results show low between-study variability with an I2 statistic of 24.4% [33].
Discussion
Additional considerations
This section addresses additional considerations for evaluating venipuncture and 
phlebotomy teams, the two practices identified as effective at reducing blood culture 
contamination rates.
Applicability
While venipuncture is demonstrated to be more effective at reducing blood culture 
contamination than intravenous catheter for blood culture collection, venipuncture and its 
effect size results are not necessarily equally applicable in all hospital settings and 
populations (e.g., pediatric units, hematology-oncology patients and other settings where 
patients are critically ill and may have in-dwelling catheters in place) [18,34–38]. Catheter 
blood collection may remain a secondary source of blood specimens for blood culture or 
other laboratory tests when there are problems with venipuncture due to poor peripheral 
access, since it is convenient and prevents trauma to the veins when blood is needed 
frequently [34] (e.g., for ruling out infection in critically ill patients in surgical intensive care 
units [39]). In addition, catheter blood collections are required to identify or rule out catheter 
colonization with bacteria, in which case catheters may need to be removed and replaced. As 
indicated by the higher contamination rates from this systematic review, interpretation of 
positive blood culture results from catheter drawn samples must be exercised with care 
[3,40].
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Phlebotomy teams are applicable to a variety of hospital environments such as tertiary care, 
community and academic medical centers, emergency departments, adult general medical 
and surgical care settings [13,16,19,41]. Based on the included studies, phlebotomy team 
results are highly applicable across several patient groups in hospital settings, but less so in 
special cases where venipuncture may be less applicable such as neonatal intensive care 
units and critically ill patients in long term care. It is important to note that well-trained and 
experienced non-phlebotomist staff can potentially achieve comparable blood culture 
contamination rates when using the same collection techniques as phlebotomists.
Harms
Venipuncture procedures should be performed using universal precautions [1], as there are 
needle stick injuries [42] and pathogen exposure risks for the phlebotomists or other 
healthcare staff drawing patient blood samples [1]. Patients are at risk for needle insertion 
site injury from multiple attempts to obtain blood specimens [42].
Additional benefits
Studies reviewed report beneficial outcomes associated with venipuncture performed by 
phlebotomists in addition to reducing blood culture contamination rates. These benefits 
include decreased turnaround time for laboratory test results on specimens other than blood 
cultures [13]; reduced frequency of misidentified and mislabeled specimens [43,44]; 
decrease in patient needle-stick bruises; improved quality of specimens; improved working 
relationships between phlebotomists and nurses; and higher levels of patient satisfaction 
[42,45].
Economic evaluation
Venipuncture, like catheter collection, is a primary means of blood sample collection for 
blood cultures; however the cost of this practice has not been evaluated. Four studies of 
phlebotomy teams included estimated and projected labor costs and healthcare savings (e.g., 
reduced hospital length of stay, pharmacy and laboratory services) associated with reduced 
blood culture contamination rates or false positives [13,16,19,41]. Some studies’ estimated 
savings were associated with either a general reduction in blood culture contamination rates 
or relied on other sources for key cost-related assumptions [13,16,19]. All four studies 
concluded that the healthcare cost savings from reduced contaminated blood cultures 
exceeded total phlebotomist labor costs, however they did not compare phlebotomist to non-
phlebotomist costs (i.e., implies $0 cost for non-phlebotomist labor). Nonetheless, these 
studies all support a conclusion that phlebotomy teams are not only cost-effective but cost-
saving solely based on reduction in blood culture contamination.
Feasibility of implementation
Venipuncture is feasible in all settings and patient populations with some special patient 
case exceptions as noted in the applicability section. The evidence reviewed clearly 
demonstrates the feasibility of adopting phlebotomy teams in a variety of hospital settings 
[13,16,41]. Implementing phlebotomy teams for blood culture collection may require 
assessment of the availability of currently trained phlebotomist staff in various areas of the 
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hospital settings and possible reorganization of resources. In settings where phlebotomy has 
been decentralized or eliminated, changes may be instituted to achieve workforce goals. 
Selected environments where high volumes of blood cultures are initiated at specific hours 
of the workday may be an excellent starting point for implementation [41]. Phlebotomist 
salaries and training costs may be perceived as initial barriers to adoption of phlebotomy 
teams, therefore an assessment of blood culture contamination rates and associated costs 
within an institution may be helpful to support perceived additional costs for implementing 
phlebotomy teams compared to using non-phlebotomist staff. Involvement from multiple, 
relevant departments and leaders within an organization to support implementation will 
likely be required [13,19,41].
Future research needs
Research is needed to identify and better clarify the impact of blood culture contamination 
on patient care and health outcomes and their associated costs. This can be accomplished in 
conjunction with new economic evaluation research to more rigorously and transparently 
demonstrate blood culture contamination clinical and economic outcomes as well as those 
associated with phlebotomy teams due to the limited cost-savings information in available 
studies. Given the evidence on higher blood culture contamination rates from catheter blood 
collections, more investigation is needed regarding practices to effectively reduce catheter 
use by non-phlebotomists (e.g., through educational interventions), and by clarifying the 
specific circumstances for its use (e.g., based on patient characteristics, only newly inserted 
catheters) to reduce contamination. More research is also needed, however, to determine 
blood culture contamination rates in patient subgroups, particularly pediatric patient 
subgroups, to refine guidance on catheter use. Research on the rate of blood culture 
contamination and quality improvement practices in relatively high volume non-hospital 
settings, such as in nursing homes and rehabilitation centers, is needed to evaluate and 
improve quality gaps in other important care settings.
Limitations
The LMBP systematic review methods are consistent with practice standards for systematic 
reviews [27], but all similar methods are imperfect and include subjective assessments at 
multiple points that may produce bias. Rating study quality depends on consensus 
assessments that may be affected by rater experience and the criteria used. Publication bias 
must be considered although this review contains unpublished studies which may help 
mitigate that bias. The restriction to English language studies to satisfy the requirement of 
multiple reviewers for each study may also introduce bias. Most of the evidence for this 
review is from quality improvement studies, thus the primary data have many limitations, 
including single institution site-specific differences which may affect study results. Many 
studies were missing information including actual study sample sizes, dates for relevant time 
periods, and practice implementation and setting characteristics. Several studies were 
conducted in specific settings within a hospital such as emergency departments, medical 
intensive care units and academic settings which may not be generalizable to other settings. 
Individual study comparison group settings were not always identical, therefore potential 
differences in practice patterns and patient clinical status could influence results.
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As noted in the Results section, several studies included in this review have study periods 
that are more than ten years old, with three dating to the early 1990s; two for venipuncture 
(DesJardin [34] and Martinez [30]); one for phlebotomy teams (Surdulescu [16]); and six of 
the seven prep kit study periods began prior to or in 2000. As indicated in the venipuncture 
results section, five of the nine studies used a paired blood culture sample study design 
comparing venipuncture and catheter blood samples from the same patient within a pre-
defined time limit, while the other four studies used group-wise comparisons. Although 
systematic differences are not observed and all nine included studies favored venipuncture, 
the non-paired design may yield less valid findings when blood culture contamination is 
affected by patient or setting characteristics. Three of the five phlebotomy team studies used 
comparison groups of non-phlebotomists performing only venipuncture collections, thereby 
controlling for the possibility of catheter contamination. Although systematic differences 
were not observed, it is likely that the results from these three studies were more 
representative of the practice’s true effect size. All five studies favored phlebotomy teams, 
but the two studies with non-phlebotomist catheter collections in the comparison group may 
have had a slight upward bias on the meta-analysis mean effect size estimate. Several studies 
in this review noted study design limitations in terms of phlebotomy teams and non-
phlebotomist staff which may have introduced confounding results on reported blood culture 
contamination rates and effect sizes due to differences in the skill level and training of staff 
performing venipuncture.
Conclusions and recommendations
On the basis of a high overall strength of evidence of effectiveness, venipuncture is 
recommended as a best practice to reduce blood culture contamination (false positive) rates 
in all hospital settings. The high overall strength of evidence rating is due to sufficient 
evidence of practice effectiveness from nine individual studies, all favoring venipuncture 
over catheter blood collection and demonstrating consistent and substantial reductions in 
blood culture contamination rates (mean odds ratio of 2.69; 95% CI: 2.03–3.57).
On the basis of a high overall strength of evidence of effectiveness, phlebotomy teams are 
recommended as a best practice to reduce blood culture contamination (false positive) rates 
in all hospital settings. The high overall strength of evidence rating is due to sufficient 
evidence of practice effectiveness from five individual studies, all favoring phlebotomy 
team over non-phlebotomist staff collection and demonstrating consistent and substantial 
reductions in blood culture contamination rates (mean odds ratio of 2.58; 95% CI: 2.07–
3.20).
On the basis of an insufficient overall strength of evidence of effectiveness, no 
recommendation is made for or against prepackaged prep kits. The overall insufficient 
strength of evidence rating is based on evidence that indicates inconsistent and unlikely 
improvement in blood culture (false positive) contamination rates compared to venipuncture 
collections without prep kits in hospital settings from the results of seven trials in a broad 
range of hospital settings by multiple types of staff. For six of the seven studies, the prep kit 
failed to significantly reduce blood culture contamination relative to a standard practice, and 
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the overall effect size was homogeneous and not statistically significantly different from 
collections without prep kits (mean odds ratio of 1.12; 95% CI: 0.94–1.35).
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Glossary
Antiseptic a substance that inhibits the growth and development of 
microorganisms without necessarily killing them.
Bacteremia the presence of bacteria in the bloodstream.
Bias systematic error; threats to validity; tendency to produce results that 
depart systematically from the ‘true’ results. Unbiased results are 
internally valid. Four types of bias are selection/allocation, 
performance, measurement/detection and attrition/exclusion.
Blood culture a specimen of blood that is submitted for bacterial or fungal culture 
[1].
Blood culture 
contamination 
rate
the number of contaminated cultures per number of blood cultures 
received by the laboratory per month or per year. Contamination 
rates vary based on laboratory-specific definitions due to variation in 
the definition of contaminant (see Contaminant definition).
Bloodstream 
infection
an infection associated with bacteremia or fungemia.
Catheter an indwelling device inserted into the vein for injection of 
medication or as an access for collection of blood samples using a 
thin flexible tube [35,36].
Consistency the degree to which estimates of effect for specific outcomes are 
similar across included studies.
Contaminant a microorganism isolated from a blood culture that was introduced 
into the culture during specimen collection or processing and that 
was not pathogenic for the patient from whom blood was collected 
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(i.e., not present in the patient’s blood when the blood was sampled 
for culture). Organisms are most commonly coagulase-negative 
Staphylococci but also include other skin flora species such as 
viridans streptococci, Corynebacterium species other than C. 
jekieum; Bacillus species, Propioonibacterium acnes [1,2,11].
Disinfectant a substance used to reduce the concentration of bacteria, fungi, or 
viruses on a surface.
External validity generalizability, applicability — extent to which the effects observed 
in the study are applicable outside of the study to other populations 
and settings.
Effect size a value which reflects the magnitude of the difference in a study’s 
outcome measure between the group with the intervention/practice 
being evaluated and its control or comparison group.
False positive 
blood culture
a culture with one or more contaminants producing a positive test 
result for a patient without a bloodstream infection. False positive 
rates are the percent of cultures contaminated relative to the total 
number of cultures positive.
Fungemia the presence of fungi (yeasts or molds) in the bloodstream.
Internal validity extent to which the design and conduct of the study are likely to 
prevent systematic error. Internal validity is a prerequisite for 
external validity.
Meta-analysis the process of using statistical methods to combine quantitatively the 
results of similar studies in an attempt to allow inferences to be made 
from the sample of studies and be applied to the population of 
interest.
Non-
phlebotomist 
staffs
hospital staff whose primary work responsibilities consist of duties 
other than collection of patient blood samples for laboratory tests by 
venipuncture [19,41].
Odds ratio the ratio of two odds of an event from two groups - a treatment or 
intervention group (a/c) versus a control group (b/d) where a and c 
represent the number of times the event occurs for the intervention 
and control group, respectively, using the formula below and the 
barcoding and comparison practice example table. An OR=1 means 
the two practices are equally successful (no difference in reducing 
risk with respect to the outcome evaluated); OR>1 means the 
barcoding practice is more successful; and OR<1 means the 
barcoding practice is less successful.
Odds ratio estimate formula: ;
Where pa = a/(a + b), pc = c/(c+d) and a, b, c, and d are proportions 
in the table below.
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Frequencies Proportions
Success Failure Success Failure
Barcoding practice A B pa = a/(a + b) pb = b/(a + b)
Comparison Practice C D pc = c/(c + d) pd = d/(c + d)
Phlebotomy team a team of trained persons with primary responsibility for collecting 
blood for laboratory evaluation using sterile technique by puncture of 
a vein [19,41].
Septicemia (also 
Bacteremia, 
Sepsis, Systemic 
inflammatory 
response 
syndrome 
(SIRS))
a serious systemic illness caused by bacteria and bacterial toxins 
circulating in the bloodstream.
Systematic 
review
a scientific investigation that focuses on a specific question and that 
uses explicit, planned scientific methods to identify, select, assess, 
and summarize the findings of similar but separate studies. It may or 
may not include a quantitative synthesis of the results from separate 
studies (meta-analysis).
Transparency methods are explicitly defined, consistently applied, and available for 
public review so that observers can readily link judgments, decisions, 
or actions to the data on which they are based. Allows users to assess 
the strengths and weaknesses of the systematic review of the 
associated guidance and recommendations.
Venipuncture puncture of a vein. A method used to collect blood specimens for 
culture removed through a sterile needle inserted into a vein [1].
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Fig. 1. 
LMBP QI analytic framework: blood culture contamination.
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Fig. 2. 
Systematic review flow diagram.
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Fig. 3. 
Meta-analysis forest plot: venipuncture versus catheter collection.
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Fig. 4. 
Meta-analysis forest plot: phlebotomy teams.
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Fig. 5. 
Meta-analysis forest plot: prepackaged prep kits.
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Table 1
Body of evidence summary table: venipuncture (versus catheter).
Study (Quality and 
Effect Size 
Ratings)
Population/Sample Setting Time period Results (Blood Culture 
Contamination Rates)
Beutz 2003
 - Good
 - Moderate
300 paired blood cultures from 
119 patients - medical ICU
Barnes - Jewish Hospital, 
St. Louis, MO: 1,000 bed 
university - affiliated 
teaching hospital
9 months (02/2001 
– 10/2001)
Venipuncture: 3.7%
Catheter: 6.7%
OR = 1.88 (CI: 0.88 – 3.99)
DesJardin 1999
 - Good
 - Moderate
551 paired blood cultures from 
185 patients – oncology ward
New England Medical 
Cente, Boston, MA; 300 - 
bed tertiary care university 
- affiliated hospital
22 months (08/1994 
– 06/1996)
Venipuncture: 2.4%
Catheter: 4.4%
OR = 1.88 (CI: 0.95 – 3.74)
Everts 2001
 - Good
 - Substantial
1,408 pairs of concurrent 
catheter-drawn and 
venipuncture samples
Tertiary - care medical 
setting; Duke University 
School of Medicine, 
Durham, NC
24 months (01/1997 
– 12/1998)
Venipuncture: 1.8%
Catheter: 3.8%
OR = 2.12 (CI: 1.32 – 3.41)
Martinez 2002
 - Good
 - Substantial
499 paired blood cultures from 
271 patients - surgical and 
cardiothoracic ICUs
New England Medical 
Center, Boston, MA; 300 - 
bed tertiary care university 
- affiliated hospital
34 months (11/1994 
– 08/1997)
Venipuncture: 1.6%
Catheter: 4.0%
OR = 2.57 (CI: 1.13 – 5.89)
Mcbryde et al. 
(2005)
- Good
- Substantial
962 paired venipuncture and 
catheter - drawn blood cultures 
from same patient – multiple 
wards
Mater Misericordiae 
Hospital, Brisbane, 
Queensland Australia; 280 
beds; Teaching hospital
44 months (01/1998 
- 08/2002)
Venipuncture: 2.6%
Catheter: 13%
OR = 5.60 (CI: 3.61 – 8.69)
Norberg 2003
 - Good
 - Substantial
4,108 total blood cultures – 
pediatric emergency department
Catheter: 2108 Venipuncture: 
2000
Children’s Hospital 
Medical Center of Akron, 
Akron, OH
12 months (01/1999 
- 12/1999)
Venipuncture: 2.8%
Catheter: 9.1%
OR = 3.46 (CI: 2.55 – 4.69)
Qamruddin et al. 
(2007)
 - Fair
 - Moderate
1,138 total blood culture 
samples – adult patients from 
multiple wards
Venipuncture: 979
Catheter: 159
Manchester Royal 
Infirmary, Manchester, 
UK.
2 months (02/2006 
- 04/2006)
Peripheral vein: 7.3%
Catheter: 10.7%
OR = 1.53 (CI: 0.88 – 2.68)
Ramsook et al. 
(2000)
 - Fair
 - Substantial
1,722 total blood cultures – 
pediatric emergency room
Venipuncture: 427
Catheter: 1295
Texas Children’s 
Hospital; Houston 
University - affiliated 
Houston, Texas
6 months (02/1999 
- 07/1999)
Venipuncture: 1.2%
Catheter: 3.4%
OR = 2.97 (CI: 1.17 – 7.54)
Weddle 2011
 - Good
 - Substantial
3,025 total blood cultures - 
pediatric emergency department
Venipuncture: 1229
Catheter: 1796
Children’s Mercy 
Hospitals and Clinics, 
Kansas City, MO. 263-bed 
tertiary children’s 
hospital.
12 months (9/2008 
- 8/2009)
Venipuncture: 2.4 (29/1229)
Catheter: 6.7% (120/1796)
OR = 2.96 (CI 1.96 – 4.47)
BODY OF EVIDENCE RATINGS # Studies by Quality and Effect Size Ratings
5 Good/Substantial
1 Fair/Substantial
2 Good/Moderate
1 Fair/Moderate
Consistency YES
Overall Strength HIGH
Bibliographic information for all studies is provided in Appendix C.
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Table 2
Body of evidence summary table: phlebotomy teams.
Study (Quality and 
Effect Size Ratings)
Population/Sample Setting Time period Results (Blood Culture 
Contamination Rates)
Gander 2009
- Good
- Substantial
3,662 total venipuncture 
blood cultaaures - Emergency 
Dept (West):
Phlebotomists: 2,012
Non -phlebotomists: 1,650
Parkland 
Memorial 
Hospital, Dallas, 
TX; 968 bed 
tertiary care 
teaching hospital
12/2006–12/2007; 5mos. of a 13-
mo. period
Phlebotomists: 3.1%
Non-phlebotomists: 
7.4%
OR = 2.51 (CI: 1.84 –
3.43)
Sheppard 2008
- Good
- Substantial
2,854 total blood cultures-
Emergency
Dept.: Phlebotomists: 278
Non-phlebotomists: 2,576 
(include venipuncture and 
catheter)
Emory Crawford 
Long Hospita, 
Atlanta, GA; 
Academic Medical 
Center
3 months– no dates reported Phlebotomists: 1.1%
Non-phlebotomists: 
5.0%
OR = 4.83 (CI: 1.53 –
15.28)
Surdulescu 1998
- Fair
- Substantial
Venipuncture blood draws 
with prep kits; Sample size 
not reported;~6,900 total for 
1995; from 1/93–10/93 
approx. ½ phlebotomy team 
draws
St. Luke’s 
Medical Center, 
Case Western 
Reserve 
University, 
Cleveland, OH; 
teaching hospital.
10 months 01/1993–10/1993 Phlebotomists: 2.6%
Non-phlebotomists: 
5.6%
(p= 0.003) OR = 2.09 
(CI: 1.68 –2.61)
Weinbaum 1997
-Good
- Substantial
1,164 total blood culture 
venipuncture draws with prep 
kits; adult general medical 
and surgical care
Phlebotomists: 956
Non-phlebotomists: 208
New York 
Medical Center 
Hospital of 
Queens, Flushing, 
NY; 487-bed 
community 
hospital
No dates reported. Baseline: 
3mos.; Intervention: 6 mos.
Phlebotomists: 1.2%
Non-phlebotomists: 
4.8%,
OR = 4.34 (CI: 1.82 –
10.36)
Unpublished
Geisinger Wyoming 
Valley Hospital 
2009
- Good
- Substantial
~7020 total blood cultures; 
73% by phlebotomists; non-
phlebotomist blood 
collections include 
venipuncture and catheter
Geisinger 
Wyoming Valley 
Hospital; Wilkes-
Barre PA
9 months (01/2009–09/2009) Phlebotomists: 1.5%
Non-phlebotomists: 
4.3%
OR = 2.93 (CI: 2.13 –
4.02)
BODY OF EVIDENCE RATINGS # Studies by Quality and Effect Size Ratings
4 Good/Substantial
1 Fair/Substantial
Consistency YES
Overall Strength HIGH
Bibliographic information for all studies is provided in Appendix C.
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Table 3
Body of evidence summary table: prepackaged prep kits.
Study (Quality 
and Effect Size 
Ratings)
Population/Sample Setting Time period Results (Blood Culture 
Contamination Rates)
McLellan 2008
-Fair
-Minimal/None
1,115 total blood cultures collected 
by Doctor Support Workers 
(DSWs), junior and on call doctors
No prep kit (Pre): 563
Prep kit (Post): 552
(2% chlorhexidine gluconate in 70% 
isopropyl alcohol)
Northern General 
Hospital, Sheffield 
Teaching Hospitals 
NHS Foundation Trust, 
Sheffield, South 
Yorkshire, UK 
Academic Medical 
Center; 2 units; 
accident/emergency 
and general practice
Pre: 5/2007- 7/2007
Post: 8/2007–
10/2007
Overall:
No prep kit (Pre): 8.88%
Prep kit (Post): 7.43 %
OR= 1.22 (CI: 0.79 –1.87)
Trautner 2002
-Fair
-Substantial
813 total blood cultures collected by 
phlebotomists, house staff (medical 
students/residents) and healthcare 
technicians
No prep kit:383
Prep kits: 430 paired
sets from 215 patients-2 separate 
sites (chlorhexidine and tincture of 
iodine)
VA Medical Center, 
Houston, TX; Tertiary-
care teaching hospital, 
inpatient service wards 
(telemetry, oncology, 
geriatric), medical and 
cardiac ICU.
11/2000–5/2001 No prep kit: 6.5%
Prep kits: 0.9%
OR = 3.68 (CI: 1.27 –10.73)
Weinbaum 1997
-Good
-Moderate
495 total blood culture specimens 
collected by house staff (interns & 
residents
No prep kit: 287
Prep kits: 208 (isopropanol and 
tincture of iodine)
New York Medica 
Center Hospital of 
Queens Flushing, NY.; 
487-bed community 
hospital); general 
medical unit
3 months (1995); 
dates not reported
No prep kit: 6.5%
Prep kits: 0.9%
OR = 1.81 (CI: 0.85 –3.87)
Wilson et al. 
(2000)
-Fair
-Minimal/None (4 
studies)
12,367 total blood samples; 6,362 
with alcohol pledgets; 6005 with 
prep kits (70% isopropyl alcohol & 
2% iodine tincture on separate 
sterile applicators). By site:
Site a: No kit: 3536; Prep kit 2924; 
Site b: No kit: 1632; Prep kit 1801; 
Site c: No kit: 1007; Prep kit 906; 
Site d: No Kit: 187; Prep kit 374; 
collected by house staff physicians/
medical students except phlebotomy 
teams at Site c.
4 Academic medical 
centers: Duke Univ. 
Med. Ctr., Durham, 
NC (Site a), Robert 
Wood Johnson Univ. 
Hosp., New 
Brunswick, NJ (Site b), 
Denver Health Med. 
Ctr., Denver, CO (Site 
c), and Salt Lake 
Veterans Affairs Med. 
Ctr., Salt Lake City, 
UT (Site d)
Dates not reported; 
prior to 2000
Overall: No prep kit: 5.5% 
Prep kits:* 5.5%
By site: Conventional; Prep 
kit
Site a: 4.4%; 4.3% OR = 
1.03 (CI: 0.81–1.31)
Site b: 8.1%; 7.5% OR = 
1.09 (CI: 0.85–1.39)
Site c: 5.5%; 6.0% OR = 
0.91 (CI: 0.62–1.34)
Site d: 3.7%; 3.5% OR = 
1.08 (CI: 0.42 –2.75)
BODY OF EVIDENCE RATINGS # Studies by Quality and Effect Size Ratings
1 Fair/Substantial
1 Good/Moderate
5 Fair/Minimal/None
Consistency NO
Overall Strength INSUFFICIENT
Bibliographic information for all studies is provided in Appendix C.
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